Answers are grounded in this paper and cite their sources.
Accurate prognostication in congenital heart disease is vital for purposes of obtaining insurance, yet can be problematic for patients, physicians and insurers. This article discusses the scope of the problem, and describes the process of evaluating life insurance. Mortality data as well as predictors of adverse outcomes for individual congenital heart lesions are reviewed. Practical tips for patients and their physicians are given to aid in successful application for insurance. To expand the possibility of future patients obtaining insurance coverage, the ongoing reporting and constant updating of very long-term survival data in congenital heart disease is emphasized.
No takes yet. Share an insight, caveat, or question.
Isabelle Vonder Muhll (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: